Asia-Pacific Plasma Protein Therapeutics Market By Product Type (Immunoglobulins, Albumin, Coagulation Factors, Alpha-1 Proteinase Inhibitor And Others) By Application (Hemophilia, Primary Immunodeficiency Disorder, Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017-2022)

Asia-Pacific Plasma Protein Therapeutics Market By Product Type (Immunoglobulins, Albumin, Coagulation Factors, Alpha-1 Proteinase Inhibitor And Others) By Application (Hemophilia, Primary Immunodeficiency Disorder, Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017-2022)

ID: 238 | Pages: 140 | December 2016 | Region: Asia Pacific


The Asia-Pacific Plasma Protein Therapeutics Market is currently estimated at USD 4,233.0 Million in 2016 and is forecasted to reach USD 8,162.6 Millon by 2022 with a significant CAGR of 11.63% in the review period. Recent years have witnessed the emergence of plasma proteins being used in the medical applications. The process of fractionating protein from plasma has become more efficient and cost saving with the technology advancements adding a significant boost to the market.

Plasma is a fluid rich with proteins and play an important role in providing immunity and blood clotting. Extracting the proteins in plasma can be helpful in carrying out medical therapies for immune deficiencies, autoimmune, bleeding and neurological disorders. These therapies treat the medical conditions by replacing the missing or deficient proteins in plasma. The treatment through plasma protein therapies involves the infusion or injection of the biological medicine to cure life-threatening chronic and genetic diseases.

Introduction of new plasma–derived therapies in the market is the key driving force for the market along with a host of others drivers that include increasing prevalence of life threatening diseases  involving neurological or immune systems like chronic inflammatory demyelinating polyneuropathy (CIPD), Ideopathic thrombocytopenic purpura (ITP) and other diseases such as Rabies, Hepatitis A&B, Tetanus and varicella. However, there are few hurdles the market must overcome to sustain in the future which including reimbursement issues, stringent regulatory policies and complexities in manufacturing

The Asia-Pacific Plasma Protein Therapeutics Market is segmented by the product type as Coagulation Factors, Immunoglobulins, alpha-1 proteinase inhibitor, albumin and others. By application the market is segmented as Secondary Immunodeficiency, Primary Immunodeficiency Disorder, Hemophilia, Idiopathic Thrombocytopenic Purpura and others. On the geographical bases the Asia-Pacific region is segmented as China, India, Japan, South Korea and Australia.

The key companies in the market for plasma protein therapeutic market are Grifols, CSL Behring, China Biologics, Biotest, Baxter, Kedrion, Shire Plc., Octapharma and Chengdu Inst.

1. Introduction                                                                                 

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

2. Research Methodology                                                                                           

                2.1 Introduction                                                                               

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

3. Overview                                                                                       

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                    

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

5. Market Segmentation                                                                                              

                5.1 By Type                                                                        

                                5.1.1 Immunoglobulins                                                 

                                5.1.2 Albumin                                                   

                                5.1.3 Coagulation Factors                                                             

                                5.1.4 Alpha-1 proteinase inhibitor                                                            

                                5.1.5 Others                                                      

                5.2 By Application                                                                           

                                5.2.1 Hemophilia                                                             

                                5.2.2 Primary Immunodeficiency Disorder                                                           

                                5.2.3 Idiopathic Thrombocytopenic Purpura                                                        

                                5.2.4 Secondary Immunodeficiency                                                        

                                5.2.5 others                                                       

6. Geographical Analysis                                                                                              

                6.1 Introduction                                                                               

                6.2 China                                                                             

                6.3 India                                                                              

                6.4 Japan                                                                            

                6.5 South Korea                                                                               

                6.6 Australia                                                                      

7. Strategic Analysis                                                                                       

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8. Market Leaders' Analysis                                                                                        

                8.1 CSL Behring                                                

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                             

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Baxter                                                           

                8.3 Biotest                                                          

                8.4 China Biologics                                                          

                8.5 Grifols                                                           

                8.6 Kedrion                                                        

                8.7 Octapharma                                                               

                8.8 Shire Plc.                                                      

                8.9 Chengdu Inst.                                                            

9. Competitive Landscape                                                                                           

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

10. Expert Opinions                                                                                        

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 

Appendix                                                                                           

                a) List of Tables                                                                

                b) List of Figures                                                                              

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Plasma Protein Therapeutics Market By Type, From 2016-2022 (USD Million)
  2. Asia-Pacific Plasma Protein Therapeutics Market By Application, From 2016-2022 (USD Million)
  3. Asia-Pacific Immunoglobulins Market By Region, From 2016-2022 (USD Million)
  4. Asia-Pacific Albumin Market By Region, From 2016-2022 (USD Million)
  5. Asia-Pacific Coagulation Factors Market By Region, From 2016-2022 (USD Million)
  6. Asia-Pacific Alpha-1 proteinase inhibitor Market By Region, From 2016-2022 (USD Million)
  7. Asia-Pacific Others Market By Region, From 2016-2022 (USD Million)
  8. Asia-Pacific Hemophilia Market By Region, From 2016-2022 (USD Million)
  9. Asia-Pacific Primary Immunodeficiency Disorder Market By Region, From 2016-2022 (USD Million)
  10. Asia-Pacific Idiopathic Thrombocytopenic Purpura Market By Region, From 2016-2022 (USD Million)
  11. Asia-Pacific Secondary Immunodeficiency Market By Region, From 2016-2022 (USD Million)
  12. Asia-Pacific Others Market By Region, From 2016-2022 (USD Million)
  13. China Plasma Protein Therapeutics Market By Type, From 2016-2022 (USD Million)
  14. India Plasma Protein Therapeutics Market By Type, From 2016-2022 (USD Million)
  15. Japan Plasma Protein Therapeutics Market By Type, From 2016-2022 (USD Million)
  16. South Korea Plasma Protein Therapeutics Market By Type, From 2016-2022 (USD Million)
  17. Australia Plasma Protein Therapeutics Market By Type, From 2016-2022 (USD Million)
  18. China Plasma Protein Therapeutics Market By Application From 2016-2022 (USD Million)
  19. India Plasma Protein Therapeutics Market By Application, From 2016-2022 (USD Million)
  20. Japan Plasma Protein Therapeutics Market By Application, From 2016-2022 (USD Million)
  21. South Korea Plasma Protein Therapeutics Market By Application, From 2016-2022 (USD Million)
  22. Australia Plasma Protein Therapeutics Market By Application, From 2016-2022 (USD Million)
Middle East And Africa Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, G...
Latin America Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Tr...
Asia Pacific Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Tre...
Europe Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, A...
North America Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Tr...
Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Fore...
Middle East And Africa Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extre...
Latin America Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepi...
Asia Pacific Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepin...
Europe Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepiness, C...
North America Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepi...
Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepiness, Cataplex...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.